Brought to you by 
Nutraceuticals company ChromaDex secures $5mm in debt from Bridge Bank
14 Nov 2016
Executive Summary
ChromaDex Corp. (nutraceuticals and OTC products) raised $5mm in debt funding from Bridge Bank. The company will use the funds for future growth and to expand its proprietary ingredient business.
Deal Industry
- Contract Research Organization-CRO
- Pharmaceuticals
- Services
-
Pharmaceuticals
- Nutraceuticals
- OTC, Consumer
-
Biotechnology
-
Drug Discovery Tools
-
Molecular Diversity
- Natural Products
-
Molecular Diversity
-
Drug Discovery Tools
Deal Status
- Final
Deal Type
-
Financing
- Nonconvertible Debt
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Nutraceuticals company ChromaDex secures $5mm in debt from Bridge Bank
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice